About the event
Tuesday, 14 October 2014 from 08:45 to 16:40
Executive Business Centre (EBC), Lansdowne Campus, BH8 8EB
The Centre of Postgraduate Medical Research and Education (CoPMRE) would like to invite you to their Eleventh Annual Symposium: Impact in Healthcare Research and Education. This symposium is suitable for primary and secondary doctors, allied healthcare professionals, academics and anyone with an interest in medical research and education.
This conference will discuss developments and activities around impact in healthcare research and education and explore impact from the perspectives of the public, the research funder, the university, the provider, the student and the medical educator. National speakers include Professor Trish Greenhalgh, Professor of Primary Care and Dean for Research Impact, Barts and the London School of Medicine and Dentistry, Simon Denegri, Chair INVOLVE, Natalie Carter, Head of Research Liaison and Evaluation, Arthritis Research UK and Jonathan Grant, Director, Kings Policy Institute.
This event is free to attend but places are strictly limited so please register as soon as possible to avoid disappointment.
For full details and to register please go to: www.bournemouth.ac.uk/symposium2014
See you there!












Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Three Minute Thesis (3MT®) 2026: Register to Support our PGRs
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease